Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study

Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study

We aimed to explore the medium- and long-term (≥12 weeks) effects of dapagliflozin on serum uric acid (SUA) level in patients with type 2 diabetes mellitus (T2DM) in the real world study and to explore the influencing factors of dapagliflozin on reducing SUA level. This observational, prospective co...

Full description

Bibliographic Details
Main Authors: Shihan Wang, Tao Yuan, Shuoning Song, Yanbei Duo, Tianyi Zhao, Junxiang Gao, Yong Fu, Yingyue Dong, Weigang Zhao
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Personalized Medicine
Subjects:
serum uric acid
dapagliflozin
type 2 diabetes mellitus
sodium glucose cotransporter 2 inhibitor
Online Access:https://www.mdpi.com/2075-4426/13/1/21

Internet

https://www.mdpi.com/2075-4426/13/1/21

Similar Items